News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
163,192 Results
Type
Article (7296)
Company Profile (15)
Press Release (155881)
Section
Business (55714)
Career Advice (350)
Deals (9779)
Drug Delivery (18)
Drug Development (22224)
Employer Resources (32)
FDA (3594)
Job Trends (3905)
News (88514)
Policy (6328)
Tag
2024 Bio NC Digital (2)
2024 Biotech Bay Standard (1)
2024 Lone Star Bio Digital (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Premier (1)
Academia (493)
Accelerated approval (1)
Adcomms (4)
Allergies (24)
Alliances (5771)
ALS (17)
Alzheimer's disease (317)
Antibody-drug conjugate (ADC) (30)
Approvals (3640)
Artificial intelligence (28)
Autoimmune disease (6)
Automation (1)
Bankruptcy (70)
Best Places to Work (3549)
BIOSECURE Act (4)
Biosimilars (27)
Biotechnology (15)
Bladder cancer (28)
Brain cancer (13)
Breast cancer (97)
Cancer (764)
Cardiovascular disease (69)
Career advice (287)
Career pathing (2)
CAR-T (33)
Cell therapy (102)
Cervical cancer (11)
Clinical research (19003)
Collaboration (122)
Compensation (59)
Complete response letters (1)
COVID-19 (543)
CRISPR (27)
C-suite (16)
Cystic fibrosis (19)
Data (860)
Depression (12)
Diabetes (86)
Diagnostics (1565)
Digital health (2)
Diversity (1)
Diversity, equity & inclusion (12)
Drug discovery (32)
Drug pricing (11)
Drug shortages (4)
Duchenne muscular dystrophy (23)
Earnings (44500)
Editorial (5)
Employer branding (5)
Employer resources (26)
Events (32340)
Executive appointments (52)
FDA (3900)
Featured Employer (6)
Frontotemporal dementia (3)
Funding (115)
Gene editing (60)
Generative AI (4)
Gene therapy (91)
GLP-1 (213)
Government (884)
Grass and pollen (1)
Guidances (29)
Healthcare (4773)
Huntington's disease (7)
IgA nephropathy (13)
Immunology and inflammation (36)
Indications (9)
Infectious disease (581)
Inflammatory bowel disease (34)
Inflation Reduction Act (1)
Influenza (18)
Intellectual property (10)
Interviews (69)
IPO (6128)
IRA (7)
Job creations (578)
Job search strategy (254)
Kidney cancer (7)
Labor market (6)
Layoffs (121)
Leadership (1)
Legal (1168)
Liver cancer (21)
Lung cancer (128)
Lymphoma (68)
Machine learning (1)
Management (10)
Manufacturing (40)
MASH (22)
Medical device (3188)
Medtech (3188)
Mergers & acquisitions (3756)
Metabolic disorders (210)
Multiple sclerosis (28)
NASH (9)
Neurodegenerative disease (21)
Neuropsychiatric disorders (11)
Neuroscience (443)
NextGen: Class of 2025 (1317)
Non-profit (863)
Northern California (774)
Now hiring (4)
Obesity (104)
Opinion (37)
Ovarian cancer (17)
Pain (17)
Pancreatic cancer (20)
Parkinson's disease (33)
Partnered (3)
Patents (37)
Patient recruitment (27)
Peanut (15)
People (4946)
Pharmaceutical (4)
Pharmacy benefit managers (2)
Phase I (4929)
Phase II (7890)
Phase III (7734)
Pipeline (655)
Podcasts (4)
Policy (15)
Postmarket research (848)
Preclinical (1696)
Press Release (16)
Prostate cancer (26)
Psychedelics (8)
Radiopharmaceuticals (80)
Rare diseases (91)
Real estate (647)
Recruiting (8)
Regulatory (4757)
Reports (12)
Research institute (413)
Resumes & cover letters (52)
Rett syndrome (3)
RSV (13)
Schizophrenia (24)
Series A (20)
Series B (10)
Sickle cell disease (24)
Southern California (582)
Special edition (5)
Spinal muscular atrophy (35)
Sponsored (4)
Startups (520)
State (1)
Stomach cancer (4)
Supply chain (12)
The Weekly (4)
United States (6279)
Vaccines (162)
Venture capitalists (6)
Webinars (1)
Weight loss (80)
Women's health (7)
Worklife (5)
Date
Today (30)
Last 7 days (268)
Last 30 days (913)
Last 365 days (10911)
2025 (2554)
2024 (11373)
2023 (12820)
2022 (15347)
2021 (15099)
2020 (13778)
2019 (10992)
2018 (8211)
2017 (8221)
2016 (7145)
2015 (8991)
2014 (6198)
2013 (4618)
2012 (5210)
2011 (5393)
2010 (4871)
Location
Africa (142)
Alabama (13)
Alaska (1)
Arizona (42)
Arkansas (1)
Asia (10082)
Australia (1464)
California (1616)
Canada (565)
China (173)
Colorado (79)
Connecticut (64)
Delaware (71)
Europe (22467)
Florida (217)
Georgia (69)
Idaho (8)
Illinois (123)
India (4)
Indiana (115)
Iowa (1)
Japan (53)
Kansas (30)
Kentucky (5)
Louisiana (3)
Maine (35)
Maryland (212)
Massachusetts (1314)
Michigan (48)
Minnesota (82)
Missouri (19)
Montana (8)
Nevada (16)
New Hampshire (16)
New Jersey (558)
New Mexico (1)
New York (497)
North Carolina (244)
North Dakota (2)
Northern California (774)
Ohio (46)
Oklahoma (3)
Oregon (2)
Pennsylvania (400)
Puerto Rico (1)
Rhode Island (3)
South America (247)
South Carolina (2)
Southern California (582)
Tennessee (15)
Texas (247)
Utah (38)
Virginia (19)
Washington D.C. (7)
Washington State (157)
West Virginia (1)
Wisconsin (11)
163,192 Results for "9".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Compensation
Average Life Sciences Salaries Up 9% in 2024, but Bonuses and Equity Values Drop:
BioSpace
Report
The 9% average salary increase from 2023 to 2024 was the largest for life sciences professionals since 2021. Several factors could be behind the spike, including companies providing higher pay because bonuses and stock compensation went down.
March 25, 2025
·
3 min read
·
Angela Gabriel
Press Releases
bioAffinity Technologies Reports Record $9.4 Million Revenue for 2024
April 1, 2025
·
11 min read
Press Releases
Primary Immune Deficiency Market Size to Reach USD 9.9 Billion by 2035, Impelled by Advancements in Targeted Therapies
February 19, 2025
·
12 min read
Press Releases
Anixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9th
April 1, 2025
·
3 min read
Press Releases
Calidi Biotherapeutics Announces Closing of $3.9 Million Registered Direct Offering and Concurrent Private Placement
April 1, 2025
·
5 min read
Press Releases
Calidi Biotherapeutics Announces Pricing of $3.9 Million Registered Direct Offering and Concurrent Private Placement
March 31, 2025
·
6 min read
Press Releases
Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year
April 2, 2025
·
3 min read
I&I
Sanofi Commits up to $1.9B for Dren Bio’s Bispecific Antibody for Autoimmune Disease
The deal is the latest in a series of Sanofi investments in its immunology portfolio. According to Sanfoi, DR-0201 can achieve deep B cell depletion, giving it the potential to reset the immune system.
March 20, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Cell Penetrating Peptide Market Size to Worth USD 9.02 Billion by 2034
February 26, 2025
·
1 min read
Press Releases
Hepion Pharmaceuticals Announces $9.0 Million Public Offering
January 22, 2025
·
4 min read
1 of 16,320
Next
